Abstract:Background Psoriasis is a long-lasting, inflammatory, continuous illness caused through T cells and characterized mainly by abnormal growth and division of keratinocytes. Currently, corticosteroids are the preferred option. However, prolonged use of traditional topical medication can lead to adverse reactions and relapse, presenting a significant therapeutic obstacle. Improved alternative treatment options are urgently required. Formononetin (FMN) is a representative component of isoflavones in Huangqi (HQ) [ Astragalus membranaceus ( Fisch. ) Bge. ]. It possesses properties that reduce inflammation, combat oxidation, inhibit tumor growth, and mimic estrogen. Although FMN has been shown to ameliorate skin barrier devastation via regulating keratinocyte apoptosis and proliferation, there are no reports of its effectiveness in treating psoriasis. Objective Through transcriptomics clues and experimental investigation, we aimed to elucidate the fundamental mechanisms underlying FMN's action on psoriasis. Materials and methods Cell viability was examined using CCK8 assay in this study. The results of analysis of differentially expressed genes (DEGs) between FMN-treated HaCaT cells and normal HaCaT cells using RNA-sequencing (RNA-seq) were presented on volcano plots and heatmap. Enrichment analysis was conducted on DEGs using Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO), and results were validated through RT-qPCR verification. After 12 days of FMN treatment in psoriasis mouse model, we gauged the PASI score and epidermis thickness. A variety of techniques were used to assess FMN's effectiveness on inhibiting inflammation and proliferation related to psoriasis, including RT-qPCR, HE staining, western blot, and immunohistochemistry (IHC). Results The findings indicated that FMN could suppress the growth of HaCaT cells using CCK8 assay (with IC 50 = 40.64 uM) and 20 uM FMN could reduce the level of tumor necrosis factor-α ( TNF-α ) and interleukin-6 ( IL-6 ) to the greatest extent. FMN-treated HaCaT cells exhibited 985 up-regulated and 855 down-regulated DEGs compared to normal HaCaT cells. GO analysis revealed that DEGs were linked to interferon (IFN) signaling pathway. Furthermore, FMN improved pathological features, which encompassed decreased erythema, scale, and thickness scores of skin lesions in psoriasis mouse model. In vivo experiments confirmed that FMN down-regulated expression of IFN-α, IFN-β, IFN-γ, decreased secretion of TNF-α and IL-17 inflammatory factors, inhibited expression of IFN-related chemokines included Cxcl9, Cxcl10, Cxcl11 and Cxcr3 and reduced expression of transcription factors p-STAT1, p-STAT3 and IFN regulatory factor 1 (IRF1) in the imiquimod (IMQ) group. Conclusions In summary, these results suggested that FMN played an anti-inflammatory and anti-proliferative role in alleviating psoriasis by inhibiting IFN signaling pathway, and FMN could be used as a potential therapeutic strategy.

Topical Application of a New Monoclonal Antibody Against Fibroblast Growth Factor 10 (FGF 10) Mitigates Propranolol-Induced Psoriasis-Like Lesions in Guinea Pigs.

Total Glucosides of Paeony Attenuates Animal Psoriasis Induced Inflammatory Response Through Inhibiting STAT1 and STAT3 Phosphorylation.

Recombinant Human Tumor Necrosis Factor Receptor Type Ⅱ - IgG Fc Fusion Protein for the Treatment of Moderate to Severe Psoriasis Vulgaris:A Multicenter, Randomized, Parallel-Group, Controlled Clinical Trial

Effects of "qinzhu Liangxue Mixture" on Expression of VEGF Nd Its Acceptor(VEGFR2) in Psoriatic Guinea Pigs

The Beneficial Effect of Total Glucosides of Paeony on Psoriatic Arthritis Links to Circulating Tregs and Th1 Cell Function

Anti-psoriatic Effects of PSORI-CM01 on Psoriasis-like Model of Guinea Pigs and Study in Activating Blood Circulation of Rats

Improved Production of Anti-FGF-2 Nanobody Using Pichia pastoris and Its Effect on Antiproliferation of Keratinocytes and Alleviation of Psoriasis

Topical application of an amygdalin analogue reduces inflammation and keratinocyte proliferation in a psoriasis mouse model

Experimental study on stromal vascular fraction mediated inhibition of skin pigmentation in guinea pigs

FGF 10 Inhibited Spinal Microglial Activation in Neuropathic Pain via PPAR- c /NF- j B Signaling

Randialic acid B and tomentosolic acid block formyl peptide receptor 1 in human neutrophils and attenuate psoriasis-like inflammation in vivo

FGF10 Attenuates Allergic Airway Inflammation in Asthma by Inhibiting PI3K/AKT/NF-κB Pathway

[Therapeutic Effect of Photodynamic Treatment for Psoriasis Vulgaris in Guinea Pigs].

Gambogic acid exhibits anti-psoriatic efficacy through inhibition of angiogenesis and inflammation

Anti-Interleukin-1 Beta/Tumor Necrosis Factor-Alpha IgY Antibodies Reduce Pathological Allergic Responses in Guinea Pigs with Allergic Rhinitis.

Ginseng saponin metabolite 20(S)-protopanaxadiol relieves pulmonary fibrosis by multiple-targets signaling pathways

678 - Patient-reported outcomes for GSK1070806, an anti-IL-18 monoclonal antibody: a phase 1b, randomised, double-blind, parallel-group placebo-controlled study of patients with atopic dermatitis

Formononetin attenuates psoriasiform inflammation by regulating interferon signaling pathway.

Therapeutic Potential of Anti-Il-1β IgY in Guinea Pigs with Allergic Asthma Induced by Ovalbumin

Heat shock protein 90 inhibitor RGRN-305 potently attenuates skin inflammation

Anti-pigmentary activity of fucoxanthin and its influence on skin mRNA expression of melanogenic molecules